Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids

Detalhes bibliográficos
Autor(a) principal: Carvalho,Maria João
Data de Publicação: 2021
Outros Autores: Nogueira-Silva,Cristina, Águas,Fernanda
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302021000300244
Resumo: Abstract Introduction: Ulipristal acetate (UPA) was introduced in clinical practice for the treatment of uterine fibroids in February 2012. During the post-marketing exposure, there were reports of liver injury and the European Medicine Agency recommended monitoring of liver enzymes for safety reasons. Objectives: The aim of this survey was to gather information about Portuguese gynaecologists’ experience with UPA regarding liver function and other complications related to UPA use. Material and methods: The study consisted of a cross-section survey among members of the Portuguese Society of Gynaecology between April and May 2018. The responders used an online platform to answer a survey that focused on safety and specific alterations in laboratory analyses of liver function considering treatment with UPA since January 2018. Results: In the period considered in this survey, 199 women were treated with UPA by the responders. Monitoring of liver function was performed in 93 women and alterations in liver function laboratory tests were reported in five cases (2.5%). In two of these cases, the past medical history was associated with liver diseases, namely alcoholic, infectious and autoimmune. The clinical course was favourable in all cases. Conclusions: Despite temporary UPA temporary suspension, this survey reinforced the need of clinical database for UPA safety monitoring, particularly regarding the possible application in selected clinical cases.
id RCAP_48d064ecb782a77c1a65c9a9731d8f2a
oai_identifier_str oai:scielo:S1646-58302021000300244
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroidsUterine fibroidLeiomyomaUlipristal acetateDrug-induced liver injury.Abstract Introduction: Ulipristal acetate (UPA) was introduced in clinical practice for the treatment of uterine fibroids in February 2012. During the post-marketing exposure, there were reports of liver injury and the European Medicine Agency recommended monitoring of liver enzymes for safety reasons. Objectives: The aim of this survey was to gather information about Portuguese gynaecologists’ experience with UPA regarding liver function and other complications related to UPA use. Material and methods: The study consisted of a cross-section survey among members of the Portuguese Society of Gynaecology between April and May 2018. The responders used an online platform to answer a survey that focused on safety and specific alterations in laboratory analyses of liver function considering treatment with UPA since January 2018. Results: In the period considered in this survey, 199 women were treated with UPA by the responders. Monitoring of liver function was performed in 93 women and alterations in liver function laboratory tests were reported in five cases (2.5%). In two of these cases, the past medical history was associated with liver diseases, namely alcoholic, infectious and autoimmune. The clinical course was favourable in all cases. Conclusions: Despite temporary UPA temporary suspension, this survey reinforced the need of clinical database for UPA safety monitoring, particularly regarding the possible application in selected clinical cases.Euromédice, Edições Médicas Lda.2021-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302021000300244Acta Obstétrica e Ginecológica Portuguesa v.15 n.3 2021reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302021000300244Carvalho,Maria JoãoNogueira-Silva,CristinaÁguas,Fernandainfo:eu-repo/semantics/openAccess2024-02-06T17:21:53Zoai:scielo:S1646-58302021000300244Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:28:45.024433Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
title Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
spellingShingle Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
Carvalho,Maria João
Uterine fibroid
Leiomyoma
Ulipristal acetate
Drug-induced liver injury.
title_short Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
title_full Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
title_fullStr Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
title_full_unstemmed Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
title_sort Survey of Portuguese gynaecologists regarding drug-induced liver injury associates with ulipristal acetate in the treatment of uterine fibroids
author Carvalho,Maria João
author_facet Carvalho,Maria João
Nogueira-Silva,Cristina
Águas,Fernanda
author_role author
author2 Nogueira-Silva,Cristina
Águas,Fernanda
author2_role author
author
dc.contributor.author.fl_str_mv Carvalho,Maria João
Nogueira-Silva,Cristina
Águas,Fernanda
dc.subject.por.fl_str_mv Uterine fibroid
Leiomyoma
Ulipristal acetate
Drug-induced liver injury.
topic Uterine fibroid
Leiomyoma
Ulipristal acetate
Drug-induced liver injury.
description Abstract Introduction: Ulipristal acetate (UPA) was introduced in clinical practice for the treatment of uterine fibroids in February 2012. During the post-marketing exposure, there were reports of liver injury and the European Medicine Agency recommended monitoring of liver enzymes for safety reasons. Objectives: The aim of this survey was to gather information about Portuguese gynaecologists’ experience with UPA regarding liver function and other complications related to UPA use. Material and methods: The study consisted of a cross-section survey among members of the Portuguese Society of Gynaecology between April and May 2018. The responders used an online platform to answer a survey that focused on safety and specific alterations in laboratory analyses of liver function considering treatment with UPA since January 2018. Results: In the period considered in this survey, 199 women were treated with UPA by the responders. Monitoring of liver function was performed in 93 women and alterations in liver function laboratory tests were reported in five cases (2.5%). In two of these cases, the past medical history was associated with liver diseases, namely alcoholic, infectious and autoimmune. The clinical course was favourable in all cases. Conclusions: Despite temporary UPA temporary suspension, this survey reinforced the need of clinical database for UPA safety monitoring, particularly regarding the possible application in selected clinical cases.
publishDate 2021
dc.date.none.fl_str_mv 2021-09-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302021000300244
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302021000300244
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302021000300244
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Euromédice, Edições Médicas Lda.
publisher.none.fl_str_mv Euromédice, Edições Médicas Lda.
dc.source.none.fl_str_mv Acta Obstétrica e Ginecológica Portuguesa v.15 n.3 2021
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137357004275712